Correlation Between IMAC Holdings and Moleculin Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IMAC Holdings and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IMAC Holdings and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IMAC Holdings and Moleculin Biotech, you can compare the effects of market volatilities on IMAC Holdings and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IMAC Holdings with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of IMAC Holdings and Moleculin Biotech.

Diversification Opportunities for IMAC Holdings and Moleculin Biotech

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between IMAC and Moleculin is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding IMAC Holdings and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and IMAC Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IMAC Holdings are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of IMAC Holdings i.e., IMAC Holdings and Moleculin Biotech go up and down completely randomly.

Pair Corralation between IMAC Holdings and Moleculin Biotech

Given the investment horizon of 90 days IMAC Holdings is expected to under-perform the Moleculin Biotech. But the stock apears to be less risky and, when comparing its historical volatility, IMAC Holdings is 1.78 times less risky than Moleculin Biotech. The stock trades about -0.17 of its potential returns per unit of risk. The Moleculin Biotech is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  254.00  in Moleculin Biotech on August 25, 2024 and sell it today you would earn a total of  19.00  from holding Moleculin Biotech or generate 7.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

IMAC Holdings  vs.  Moleculin Biotech

 Performance 
       Timeline  
IMAC Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IMAC Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Moleculin Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Moleculin Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

IMAC Holdings and Moleculin Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IMAC Holdings and Moleculin Biotech

The main advantage of trading using opposite IMAC Holdings and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IMAC Holdings position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.
The idea behind IMAC Holdings and Moleculin Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators